Vasant Kusumakar Rasa: The Classical Formula for Diabetes and Aging

Vasant Kusumakar Rasa Diabetes Research: Pharmacology of a Classical Gold-Silver Rasa Formula

Vasant Kusumakar Rasa is a classical Ayurvedic herbo-mineral formulation used in the Prameha and Madhumeha context, especially where blood-sugar disturbance is accompanied by weakness, excessive urination, tissue depletion, low vitality, or age-related decline. Although it is often introduced as a gold-and-silver preparation because it contains Svarna Bhasma and Rajata Bhasma, its identity is broader: it is a Rasa Shastra formula containing multiple processed metals, minerals, animal-derived substances, and herbal levigation media. Its traditional place is therefore not as a simple “anti-diabetic tablet,” but as a potent Rasayana and Vajikarana medicine used only under expert supervision.

The more accurate pharmacological reading of this formula begins with its corrected composition. Popular summaries often add ingredients such as saffron or shatavari, but standard descriptions and analytical work describe a matrix built from Svarna, Rajata, Vanga, Naga, Loha, Abhraka, Pravala, processed pearl, Rasa Sindura, and repeated bhavana with selected herbal and milk-based media. This complexity is central to how Vasant Kusumakar Rasa is understood in Ayurveda: the mineral base gives it the depth of a rasaushadhi, while the bhavana dravyas refine its direction toward Prameha, debility, ojas support, and rejuvenation.

Corrected Classical Composition

The following table presents the corrected ingredient framework using the standard herbo-mineral profile, with emphasis on what each component contributes to the formula’s classical and analytical identity. The formulation should be understood as a processed compound, not as a mixture of raw metals or casually interchangeable ingredients.

Prameha and Madhumeha Orientation

In Ayurveda, Vasant Kusumakar Rasa belongs to the clinical world of Prameha and Madhumeha rather than to a single biomedical diagnosis. Prameha includes urinary and metabolic presentations with kapha, meda, kleda, dhatu, and ojas involvement; Madhumeha is commonly discussed in modern Ayurvedic writing alongside diabetes mellitus. The formula is traditionally valued when the Prameha picture includes exhaustion, excessive urination, loss of strength, reduced vitality, and the need for Rasayana support.

A small prospective clinical add-on study in patients of Madhumeha used Vasant Kusumakar Ras 125 mg twice daily with lukewarm water before meals for one month while patients continued their regular diabetes medicines. The treated group included 37 patients and the control group included 31 patients on standard protocol medicines. The measured parameters included blood sugar level, Madhumeha symptoms, psychological traits, and psychiatric rating scale, with improvement reported in the Vasant Kusumakar group. This supports its interpretation as a supervised adjunct in selected patients, not as a substitute for glucose monitoring, diet, exercise, or prescribed diabetes medication.

Experimental Pharmacology in Diabetic Complication Models

The most relevant experimental work on Vasant Kusumakar Rasa has focused on diabetic complications rather than on simple blood-sugar lowering alone. In a rat model of diabetic retinopathy, diabetes was induced with streptozotocin, followed by oral Vasant Kusumakar Ras treatment for five weeks. The evaluated endpoints included fasting blood glucose, lipid profile, HbA1c, antioxidant markers in eye tissue, aldose reductase activity, vascular endothelial growth factor, and retinal histology. The treated animals showed improvement across several of these biochemical and tissue parameters, giving a plausible modern frame for why the classical Prameha use extends to complication-prone metabolic states.

Another experimental animal model evaluated Vasant Kusumakar Rasa in diabetic encephalopathy over a 16-week period, focusing on oxidative stress, neuroinflammatory markers, and neurotransmitter levels. This is consistent with the classical idea that a Rasayana used in Madhumeha should not be judged only by glucose readings; it is intended to support deeper tissue function, vitality, and organ resilience in a chronic metabolic condition.

Analytical Quality and Why Manufacturing Matters

Vasant Kusumakar Rasa is not a household supplement. Standard preparation includes multiple demanding stages: preparation of Rasa Sindura, preparation of Pravala, Abhraka, Rajata, Svarna, Lauha, Naga, and Vanga bhasmas, preparation of pearl material, repeated bhavana with specified liquids, and conversion into tablets. In one chemical characterization project, the formulation was prepared in a GMP-certified pharmacy and tablets of 125 mg were produced after classical processing steps.

The same characterization work described a bitter-astringent brown tablet and reported elements such as tin, gold, silver, iron, zinc, calcium, mercury, sulphur, lead, and silica. Pesticide and microbiological testing were also included in the analytical profile. This kind of quality work is important because the safety and identity of a rasaushadhi depend on source material, shodhana, marana, bhavana, batch testing, and correct clinical use. A market product without transparent manufacturing and testing should not be treated as equivalent to a properly prepared classical formulation.

Clinical Dose and Anupana

Commonly cited adult dosing for Vasant Kusumakar Rasa is 125–250 mg per day or as directed by an Ayurvedic physician, while some clinical and product contexts use 125 mg once or twice daily depending on the patient and indication. The dose, timing, and duration must be individualized because the formulation contains potent processed metals and minerals. Long, unsupervised courses are inappropriate.

• General Rasayana use: Traditionally paired with honey, ghee, sugar, or milk according to the patient’s constitution, disease state, and digestive strength.
• Prameha / Madhumeha context: Used only under physician supervision, sometimes alongside other Prameha medicines such as haridra-based or Nishamalaki-type support.
• Debility and dhatu-kshaya context: Milk, ghee, or other nourishing anupana may be selected when the physician wants a brmhana and Rasayana direction.
• Honey-ghee rule: If honey and ghee are used together, classical Ayurveda avoids equal quantities by weight; therapeutic use should follow the physician’s specified ratio.

Safety, Contraindications, and Heavy Metal Considerations

The safety issue cannot be separated from the formula’s identity. Vasant Kusumakar Rasa contains processed mineral and metal preparations, including mercury sulphide and lead bhasma. Classical Ayurveda treats these substances as medicines only after specialized processing and only in precise dose, indication, anupana, and duration. Modern safety practice adds another requirement: purchase only from reliable licensed manufacturers that can provide quality-control confidence for raw materials, processing, microbial limits, and elemental profile.

• Do not self-prescribe Vasant Kusumakar Rasa.
• Use only under a qualified Ayurvedic physician trained in Rasa Shastra.
• Avoid during pregnancy, breastfeeding, and childhood unless a specialist physician takes direct responsibility.
• Use extreme caution in kidney disease, liver disease, anemia of unknown cause, neurological symptoms, or known heavy-metal exposure.
• Patients taking insulin, sulfonylureas, metformin, SGLT2 inhibitors, GLP-1 medicines, blood-pressure medicines, anticoagulants, or kidney-affecting medicines should involve their treating doctor.
• For longer physician-directed use, periodic monitoring of blood sugar, HbA1c, renal function, liver enzymes, complete blood count, and relevant heavy-metal exposure markers may be appropriate.

Practical Interpretation for Diabetes Care

The strongest verified place for Vasant Kusumakar Rasa is as a classical Rasayana-Prameha formulation for carefully selected patients with chronic metabolic weakness, urinary symptoms, fatigue, and dhatu-kshaya features. Its experimental pharmacology is most interesting around oxidative stress, lipid disturbance, retinal protection pathways, neuroinflammation, and tissue-level complications of diabetes. Its clinical use should remain individualized and adjunctive, with routine diabetes care continuing in parallel.

Vasant Kusumakar Rasa should not be presented as a stand-alone diabetes cure or as a direct replacement for metformin, insulin, diet, exercise, or medical monitoring. Its value lies in the classical Ayurvedic logic of Prameha management: support agni, reduce pathological kleda and kapha-meda burden where appropriate, protect dhatu, maintain ojas, and address the exhaustion that often accompanies long-standing metabolic disease.

Medical Disclaimer: Vasant Kusumakar Rasa is a potent classical Ayurvedic herbo-mineral formulation that must only be prescribed and monitored by a qualified Ayurvedic physician with Rasa Shastra training. It does not replace conventional diabetes management, including prescribed medication, dietary modification, exercise, and blood-sugar monitoring. Do not start, stop, or combine it with diabetes medicines without guidance from your physician and Ayurvedic practitioner.

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified healthcare provider before starting herbs, supplements, rasaushadhi medicines, detoxes, or therapeutic protocols, especially if pregnant, breastfeeding, managing a chronic condition, or taking medication.

References

1. Ayurmedinfo (ayurmedinfo.com)
2. Researchgate (researchgate.net)
3. Ayurvedic Pharmacopoeia of India
4. Chemical Characterization of an Ayurvedic Herbo-Mineral Formulation – Vasantakusumākara Rasa: A Potential Tool for Quality Assurance (2017), PubMed
5. Ijam (ijam.co.in)
6. Vasant Kusmakar Ras, an ayurvedic herbo-mineral formulation prevents the development of diabetic retinopathy in rats (2020), PubMed
7. Vasant Kusumakar Rasa Ameliorates Diabetic Encephalopathy by Reducing Oxidative Stress and Neuroinflammation and Improving Neurotransmitter Levels in Experimental Animals (2024), PubMed
8. Wjpr (wjpr.s3.ap-south-1.amazonaws.com)
9. Viruddha Ahara: A critical view (2012), PubMed Central
10. NCCIH
11. Ayush (ayush.delhi.gov.in)